0001824134-22-000001.txt : 20220915 0001824134-22-000001.hdr.sgml : 20220915 20220915165101 ACCESSION NUMBER: 0001824134-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220915 DATE AS OF CHANGE: 20220915 EFFECTIVENESS DATE: 20220915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioIntelliSense, Inc. CENTRAL INDEX KEY: 0001824134 IRS NUMBER: 830671724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-459029 FILM NUMBER: 221246295 BUSINESS ADDRESS: STREET 1: 17301 W. COLFAX AVENUE STREET 2: SUITE 152 CITY: GOLDEN STATE: CO ZIP: 80401 BUSINESS PHONE: 303-578-2648 MAIL ADDRESS: STREET 1: 17301 W. COLFAX AVENUE STREET 2: SUITE 152 CITY: GOLDEN STATE: CO ZIP: 80401 FORMER COMPANY: FORMER CONFORMED NAME: BioIntellisense, Inc. DATE OF NAME CHANGE: 20200909 D 1 primary_doc.xml X0708 D LIVE 0001824134 BioIntelliSense, Inc. 17301 W. COLFAX AVENUE SUITE 152 GOLDEN CO COLORADO 80401 303-578-2648 DELAWARE BioIntellisense, Inc. Corporation true 2018 James R. Mault 17301 W. Colfax Ave Suite 152 Golden CO COLORADO 80401 Executive Officer Director John Driscoll 17301 W. Colfax Ave Suite 152 Golden CO COLORADO 80401 Director Alan Meeker 17301 W. Colfax Ave Suite 152 Golden CO COLORADO 80401 Director Steve Hess 17301 W. Colfax Ave Suite 152 Golden CO COLORADO 80401 Director Lawrence Leisure 17301 W. Colfax Ave Suite 152 Golden CO COLORADO 80401 Director David Wang 17301 W. Colfax Ave Suite 152 Golden CO COLORADO 80401 Executive Officer Other Health Care Decline to Disclose 06b false 2021-04-07 false true true Offering of Series B Preferred Stock ("Series B") and the underlying shares of Common Stock issuable upon conversion of Series B. false 0 44985854 44985854 0 false 16 0 0 0 false BioIntelliSense, Inc. /s/ James R. Mault James R. Mault Chief Executive Officer 2022-09-15